BridgeMD
Compares treatment options for Bradyarrhythmia
Official title PReventive Effect Of Left Bundle Branch Area Pacing Versus righT vEntricular paCing on All Cause deaTh, Heart Failure Progression, and Ventricular dysSYNChrony in Patients With Substantial Ventricular Pacing (PROTECT-SYNC): Multicenter Prospective Randomized Controlled Trial
ClinicalTrials.gov ID: NCT05585411
What this study is testing
- What it's testing
- PROTECT-SYNC study is a multicenter, randomized, controlled trial. A total of 7 medical centers across Republic of Korea will enroll 450 patients during 2 years of enrollment period, and followed for 2 years of follow-up period.
- Time commitment: about 2 years
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- At least 19 years old and willing and capable to give informed consent
- Patients who is willing and able to comply with the prescribed follow-up tests and schedule of evaluations. 3 Scheduled to receive a pacemaker...
You likely can't join if
- Incapacitated or unable to read or write
- Patient who is an indication of ICD or CRT
- History of prosthetic valve surgery on tricuspid valve
- Prior myocardial infarction including ventricular septum
- Life expectancy \< 12 months due to any condition
- Unavailable for at least 24 months of follow-up visits
See the full eligibility criteria
- At least 19 years old and willing and capable to give informed consent
- Patients who is willing and able to comply with the prescribed follow-up tests and schedule of evaluations. 3 Scheduled to receive a pacemaker implant 4. Substantial percentage of V pacing rate (\>40%) is anticipated
- Incapacitated or unable to read or write
- Patient who is an indication of ICD or CRT
- History of prosthetic valve surgery on tricuspid valve
- Prior myocardial infarction including ventricular septum
- Life expectancy \< 12 months due to any condition
- Unavailable for at least 24 months of follow-up visits
- Pregnant or breastfeeding at the time of signing consent
- Prior Heart transplant surgery
- Persistent Left Superior Vena Cava (PLSVC)
The study team makes the final eligibility decision.
Where it's taking place
- Bucheon-si, South Korea
- Changwon, South Korea
- Chungju, South Korea
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 2 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bucheon-si, South Korea; Changwon, South Korea; Chungju, South Korea; Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.